
Date de parution
Contenu texte de l’actualité
Olivier Giré, COO Specialty Pharma, will attend the Invest Securities Biomed Forum to present Crossject to investors.
Olivier Giré, COO Specialty Pharma, will attend the Invest Securities Biomed Forum to present Crossject to investors.
Copyright © 2024 CROSSJECT – VERSION BETA TEST